Skip to main content

Cytonus Therapeutics

Carlsbad, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

$11.7M raised
Nov 2023
Series A

Top Investors

Creative VenturesNational Institutes of HealthPartners InvestmentWilson Sonsini Goodrich & RosatiCalifornia Institute for Regenerative Medicine

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cytonus Therapeutics

How much funding has Cytonus Therapeutics raised?
Cytonus Therapeutics has raised $11.7M in total funding. The most recent round was Series A. The last funding was announced in November 2023.
Who are Cytonus Therapeutics's investors?
Cytonus Therapeutics's investors include Creative Ventures, National Institutes of Health, Partners Investment, Wilson Sonsini Goodrich & Rosati, California Institute for Regenerative Medicine.
Where is Cytonus Therapeutics headquartered?
Cytonus Therapeutics is headquartered in Carlsbad, United States.
What does Cytonus Therapeutics do?
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
What stage is Cytonus Therapeutics at?
Cytonus Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cytonus Therapeutics — Funding & Investors." VCBacked, November 3, 2023, https://www.vcbacked.co/company/cytonus-therapeutics. Accessed June 30, 2026.
APA
VCBacked. (2023). Cytonus Therapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/cytonus-therapeutics
Wikipedia (cite web)
{{cite web |title=Cytonus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cytonus-therapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .